Sorli Redó, M. L., Luque Pardos, S., Li, J., Benítez-Cano, A., Fernández, X., Prim, N., . . . Horcajada Gallego, J. P. (2023). Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant Pseudomonas aeruginosa.
Citación estilo ChicagoSorli Redó, M. Luisa, et al. Colistin Plasma Concentrations Are Not Associated With Better Clinical Outcomes in Patients With Pneumonia Caused By Extremely Drug-resistant Pseudomonas Aeruginosa. 2023.
Cita MLASorli Redó, M. Luisa, et al. Colistin Plasma Concentrations Are Not Associated With Better Clinical Outcomes in Patients With Pneumonia Caused By Extremely Drug-resistant Pseudomonas Aeruginosa. 2023.
Precaución: Estas citas no son 100% exactas.